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Abstract 
Glomerulonephritis (GN) is one of the most common causes of chronic kidney disease (CKD). In our 
studies, we investigated the molecular mechanisms behind GN on both transcriptomic and proteomic levels 
using a combined in vivo and in vitro approach. By doing so, our aim was to find new possible candidates 
for therapeutic intervention in CKD. IgA nephropathy (IgAN) is the most common type of GN worldwide. 
It is a proliferative glomerular kidney disease in which galactose-deficient IgA (gd-IgA) is deposited in the 
mesangial area of the glomeruli. Previous studies have pointed out that gd-IgA is not the only factor 
inducing the disease. Our hypothesis is that the mesangial cells are of great importance in IgAN 
development and that patients with IgAN have more susceptible mesangial cells to gd-IgA compared to 
healthy individuals. The deposition of gd-IgA is likely caused by interaction with a receptor on the 
mesangial cell leading to proliferation and inflammation. To study these mechanisms, we cultured primary 
human mesangial cells from IgAN patient biopsy samples and healthy controls. Our results showed that 
patient mesangial cells had a significantly increased release of the growth factors PDGF, TGFβ1 as well as 
the cytokines IL-6 and CCL5, when treated with gd-IgA. These cells also had a significantly higher 
proliferation rate compared to control cells. We investigated the mesangial cell transcriptomic and 
proteomic function in patients with IgAN using microarray and mass spectrometry techniques. We 
demonstrated that many inflammatory pathways were significantly regulated both in the glomeruli and in 
the gd-IgA treated mesangial cells. By using cell-type specific positive standard genes we found a dominant 
role in IgAN of the mesangial cell compared to the podocytes. The transformed z-scores based on mesangial 
cell standard genes showed significant correlation with patient clinical data (eGFR and serum creatinine). In 
order to know how gd-IgA is deposited in the mesangium, we investigated receptors from the mesangial 
cells interacting with gd-IgA. Interestingly, a transmembrane receptor was identified to be associated with 
gd-IgA and it also regulated mesangial cell proliferation. Additionally, we investigated micro-RNAs in 
glomerular disease using a screening technique. MiR-x7 was found to regulate a specific podocyte protein 
and the level was correlated to disease. Since it is a small molecule, miR-x7 can be detected in urine 
samples and may be used as a diagnostic marker for CKD. 
In conclusion, we have verified the importance of mesangial cells in IgAN. The correlation of mesangial 
cell standard genes with clinical data can potentially explain the progression of the disease. A specific 
receptor was found to regulate the proliferation of the mesangial cells and it may potentially be involved in 
the deposition of gd-IgA. Micro-RNAs are found to be promising markers for CKD and thus disease-
specific micro-RNAs should be further investigated. 
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